Evidence map›Paper›PMID 38932319›Full record

ReviewVaccines2024

Noroviruses: Evolutionary Dynamics, Epidemiology, Pathogenesis, and Vaccine Advances-A Comprehensive Review.

Cornelius Arome Omatola, Philip Paul Mshelbwala, Martin-Luther Oseni Okolo, Anyebe Bernard Onoja, Joseph Oyiguh Abraham, David Moses Adaji, Sunday Ocholi Samson, Therisa Ojomideju Okeme, Ruth Foluke Aminu, Monday Eneojo Akor and 10 more

Abstract readReview
In one paragraph

Review in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Phylogenetic Analyses ofMicroorganisms · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. [Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Detection of Genogroup Ⅱ Norovirus].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  12. Applied and environmental microbiology · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Gut Microbiota and Colorectal Cancer: A Balance Between Risk and Protection.International journal of molecular sciences · 2025
    Review
  19. Article
  20. Detection ofInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Cornelius Arome OmatolaDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.ORCID 0000-0002-5928-7240
Philip Paul MshelbwalaDepartment of Primary Industries, Orange 2800, NSW, Australia.ORCID 0000-0002-6834-1456
Martin-Luther Oseni OkoloDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Anyebe Bernard OnojaDepartment of Virology, University College Hospital, Ibadan 211101, Oyo State, Nigeria.
Joseph Oyiguh AbrahamDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
David Moses AdajiDepartment of Biotechnology Science and Engineering, University of Alabama, Huntsville, AL 35899, USA.
Sunday Ocholi SamsonDepartment of Molecular Biology, Biotechnology, and Biochemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 29, 50-370 Wrocław, Poland.
Therisa Ojomideju OkemeDepartment of Biological Sciences, Federal University Lokoja, Lokoja 260101, Kogi State, Nigeria.
Ruth Foluke AminuDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Monday Eneojo AkorDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.ORCID 0009-0000-5722-2067
Gideon AyeniDepartment of Biochemistry, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Danjuma MuhammedEpidemiology and Public Health Unit, Department of Biology, Universiti Putra, Seri Kembangan 43300, Malaysia.
Phoebe Queen AkohDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Danjuma Salisu IbrahimDepartment of Microbiology, Federal University Oye, Oye 371101, Ekiti State, Nigeria.
Emmanuel EdegboDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Lamidi YusufDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Helen Ojomachenwu OceanDepartment of Microbiology, Salem University, Lokoja 260101, Kogi State, Nigeria.
Sumaila Ndah AkpalaDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Oiza Aishat MusaDepartment of Microbiology, Kogi State University, Anyigba 272102, Kogi State, Nigeria.
Andrew Musa AdamuAustralian Institute of Tropical Health and Medicine, James Cook University, Townsville 4811, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noroviruses constitute a significant aetiology of sporadic and epidemic gastroenteritis in human hosts worldwide, especially among young children, the elderly, and immunocompromised patients. The low infectious dose of the virus, protracted shedding in faeces, and the ability to persist in the environment promote viral transmission in different socioeconomic settings. Considering the substantial disease burden across healthcare and community settings and the difficulty in controlling the disease, we review aspects related to current knowledge about norovirus biology, mechanisms driving the evolutionary trends, epidemiology and molecular diversity, pathogenic mechanism, and immunity to viral infection. Additionally, we discuss the reservoir hosts, intra-inter host dynamics, and potential eco-evolutionary significance. Finally, we review norovirus vaccines in the development pipeline and further discuss the various host and pathogen factors that may complicate vaccine development.

Indexed as

diarrhoeaevolutionmolecular diversitynoroviruspathogenesisvaccine

Identifiers

PMID38932319
PMCPMC11209302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.